Meng Zhang Editor at IgMin Research
We aim to connect experts across disciplines to create new pathways for growth.
Biography
2020.11-now, Principal Investigator, the First Affiliated Hospital, School of Medicine, Zhejiang University
2020.03-2020.09, Research fellow, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences
2015.09 – 2020.01, Ph.D., Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China
2016.01-2016.06, Cooperation in Dr. Jacob Hanna’s lab (Weizmann institute of science, Israel)
2012.09 – 2015.06, M.S., An’hui University, Hefei, China
2008.09 – 2012.06, Bachelor Degree of Biotechnology, He’nan Normal University, Xinxiang, China
Research Interest
Erythroid differentiation of pluripotent stem cells (PSCs) is an important research direction to alleviate the clinical "blood shortage" problem, but the erythroid cells from iPSCs are not mature enough to meet the clinical standards. Our team focus on to optimize the differentiation system from PSCs by screening with small molecular library and Crispr/Cas9 library to solve the problem of poor efficiency of enucleation. We also explore the epigenetic and transcriptional mechanism of terminal erythropoiesis.
Editor
Work Details
Principal Investigator
Zhejiang University
The First Affiliated Hospital, School of Medicine
China
Contribution by Topic Area
PUBLISH YOUR RESEARCH
We publish a wide range of article types in biology, medicine and engineering with no editorial biases.
SubmitSee Manuscript Guidelines and APC
Explore the IgMin Subjects
Which articles are now trending?
Research Articles
- Correlation between Different Factors of Non-point Source Pollution in Yangtze River Basin
- Wishful Thinking or Valuable Forecasts? The Value of Policy Rate Predictions in Sweden
- Preparing for SpaceX Mission to Mars
- Investigation of Lateral Vibrations in Turbine-generator Unit 5 of the Inga 2 Hydroelectric Power Plant
- Slip Resistance Evaluation of 10 Indoor Floor Surfaces
- Examining the Causal Connection between Lipid-lowering Medications and Malignant Meningiomas through Drug-target Mendelian Randomization Analysis
